[{"Assets_0_Q3_USD":26001610.0,"CommonStockSharesOutstanding_0_Q3_shares":27070038.0,"NetIncomeLoss_1_Q3_USD":-4649567.0,"NetIncomeLoss_3_Q3_USD":-15165577.0,"StockholdersEquity_0_Q3_USD":23415377.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171113"}]